News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Quart Barry D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Exercised 5,000 options to buy
@ $0 |
|
| 06/08/2023 |
4
| Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 26,236 options to buy
@ $15.19, valued at
$398.5k
Granted 4,373 options to buy
@ $0 |
|
| 01/20/2023 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 850,000 options to buy
@ $3.13, valued at
$2.7M
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 5,219 shares
@ $3.76, valued at
$19.6k
Exercised 3,646 restricted stock units
@ $0
Exercised 16,122 restricted stock units
@ $0 |
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/15/2022 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 5,219 shares
@ $6.07, valued at
$31.7k
Exercised 3,646 restricted stock units
@ $0
Exercised 16,122 restricted stock units
@ $0 |
|
| 01/14/2022 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 5,219 shares
@ $8.3, valued at
$43.3k
Exercised 3,646 restricted stock units
@ $0
Exercised 16,122 restricted stock units
@ $0 |
|
| 10/15/2021 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Paid exercise price by delivering 963 shares
@ $10.55, valued at
$10.2k
Exercised 3,646 restricted stock units
@ $0
Granted 390,834 options to buy
@ $10.55, valued at
$4.1M
Granted 195,417 restricted stock units
@ $0 |
|
| 07/15/2021 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 1,529 shares
@ $13.8975, valued at
$21.2k
Paid exercise price by delivering 963 shares
@ $13.48, valued at
$13k
Exercised 3,645 restricted stock units
@ $0 |
|
| 06/30/2021 |
4
| Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 33,237 options to buy
@ $14.33, valued at
$476.3k
|
|
| 04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2020 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 1,158 shares
@ $12.121, valued at
$14k
Granted 350,000 options to buy
@ $15.72, valued at
$5.5M
Granted 58,333 restricted stock units
@ $0 |
|
| 07/02/2020 |
4
| Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 18,760 options to buy
@ $25.48, valued at
$478k
|
|
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/30/2019 |
4
| Quart Barry D (Director) has filed a Form 4 on Kiniksa Pharmaceuticals, Ltd.|
Txns:
| Granted 18,760 options to buy
@ $15.47, valued at
$290.2k
|
|
| 12/18/2018 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 300,000 options to buy
@ $24.97, valued at
$7.5M
|
|
| 09/14/2018 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Exercised 19,675 options to buy
@ $7.2, valued at
$141.7k
|
|
| 06/22/2018 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 1,607 shares
@ $13.2175, valued at
$21.2k
Sold 50,000 shares
@ $39.05, valued at
$2M
Exercised 50,000 options to buy
@ $9.05, valued at
$452.5k
|
|
| 03/19/2018 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Sold 100,000 shares
@ $29.75, valued at
$3M
Exercised 100,000 options to buy
@ $7.2, valued at
$720k
|
|
| 03/16/2018 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Sold 100,000 shares
@ $24.75, valued at
$2.5M
Exercised 100,000 options to buy
@ $7.2, valued at
$720k
|
|
| 12/20/2017 |
4
| Quart Barry D (CEO) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Acquired 1,684 shares
@ $12.6225, valued at
$21.3k
Granted 310,000 options to buy
@ $17, valued at
$5.3M
|
|
| 12/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2013 |
4
| Quart Barry D (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 7,500 options to buy
@ $40.32, valued at
$302.4k
|
|
| 05/03/2013 |
4
| Quart Barry D (CEO) has filed a Form 4 on AP PHARMA INC /DE/|
Txns:
| Granted 22,500,000 options to buy
@ $0.36, valued at
$8.1M
|
|
| 06/29/2012 |
4
| Quart Barry D (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 7,500 options to buy
@ $40.74, valued at
$305.6k
|
|
| 06/20/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/29/2011 |
4
| Quart Barry D (President and CEO) has filed a Form 4 on Ardea Biosciences, Inc./DE|
Txns:
| Gifted 5,000 shares
@ $0 |
|
|
|
|